Advances in Chemical Synthesis of Fondaparinux
Joint Authors
Ding, Yili
Vara Prasad, Chamakura V. N. S.
Wang, Bingyun
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-17, 17 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-05-12
Country of Publication
Egypt
No. of Pages
17
Main Subjects
Abstract EN
Fondaparinux (trade name Arixtra) is a safe and efficacious anticoagulant, and it is chemically related to low-molecular-weight heparins such as enoxaparin.
Fondaparinux is a synthetic pentasaccharide, and its synthesis is difficult and expensive.
The high cost of fondaparinux thwarts its extensive worldwide usage.
Over the last two decades, several research groups and pharmaceutical companies have been interested in finding efficient and practical methods for its synthesis.
The present review discusses those strategies and their pros and cons in a comparative account.
American Psychological Association (APA)
Ding, Yili& Vara Prasad, Chamakura V. N. S.& Wang, Bingyun. 2019. Advances in Chemical Synthesis of Fondaparinux. Journal of Chemistry،Vol. 2019, no. 2019, pp.1-17.
https://search.emarefa.net/detail/BIM-1172070
Modern Language Association (MLA)
Ding, Yili…[et al.]. Advances in Chemical Synthesis of Fondaparinux. Journal of Chemistry No. 2019 (2019), pp.1-17.
https://search.emarefa.net/detail/BIM-1172070
American Medical Association (AMA)
Ding, Yili& Vara Prasad, Chamakura V. N. S.& Wang, Bingyun. Advances in Chemical Synthesis of Fondaparinux. Journal of Chemistry. 2019. Vol. 2019, no. 2019, pp.1-17.
https://search.emarefa.net/detail/BIM-1172070
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1172070
